idis Partner for life

WIPO WIPO 2012

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke idis Partner for life wurde als Bildmarke am 31.05.2012 bei der Weltorganisation für geistiges Eigentum angemeldet.

Logodesign (Wiener Klassifikation)

#Briefe, die eine besondere Form des Schreibens darstellen #Buchstabenreihen in verschiedenen Dimensionen

Markendetails Letztes Update: 13. Dezember 2022

Markenform Bildmarke
Aktenzeichen 1160827
Registernummer 2589035
Länder Australien China Südkorea Singapur Türkei
Basismarke GB Nr. 2589035, 25. Juli 2011
Anmeldedatum 31. Mai 2012
Ablaufdatum 31. Mai 2022

Markeninhaber

IDIS House, Churchfield Road
Weybridge, Surrey KT13 8DB
GB

Markenvertreter

200 Aldersgate London EC1A 4HD GB

Waren und Dienstleistungen

35 Advertising; business management; business administration; office functions; business services; business consultancy services; procurement of goods; procurement of medicines; procurement, namely, purchasing of pharmaceutical products, medicines and drugs for others; sourcing and supply of pharmaceutical products, medicines and drugs for customers; provision of business support; business advisory, business management, business information and consultancy services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and distribution solutions; provision of business networking services; collection and processing of customer requirements and data; business marketing agency services; database stock control; compilation of information into computer databases; compilation and provision of business information; processing, analysis, retrieval and presentation of business data; data processing; sales force management; retail services and wholesale services related to the sale of pharmaceutical preparations and substances, drugs and medicines; information, advisory and consultancy services, namely, business information and business advisory services in the fields of medical devices and pharmaceuticals and business consultancy services in the field of early access programs and clinical trials; information, advisory and consultancy services relating to all the aforesaid services; including all of the aforesaid services provided online from a computer database or the internet or delivered via online channels
42 Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and scientific research services; medical and scientific research, namely, conducting clinical trials; medical and scientific research, namely, managing and conducting clinical trials for others not for business purposes; preparation of expert scientific reports in the fields of pharmaceutical research and clinical trials; clinical trials services; electronic storage of customer data including data on customer requirements; electronic storage of information; electronic storage of data; provision of scientific information; analysis, retrieval and presentation of scientific data including all the aforesaid services provided online from a computer database or the Internet
44 Medical services; medical consultancy and advisory services in connection with pharmaceutical preparations and substances, drugs and medicines; provision of information on pharmaceuticals, drugs and medicine; provision of medical information; analysis, retrieval and presentation of medical data including all the aforesaid services provided online from a computer database or the Internet
45 Regulatory affairs consultancy; regulatory affairs consultancy for the purpose of ensuring compliance with laws and regulations pertaining to pharmaceutical products, medicines and drugs, namely, reviewing and formulating standards and practices, identifying government regulations and policies impacting on pricing and reimbursement and developing strategies to manage them, advising others on regulatory requirements, liaising with, and making presentations to, regulatory authorities, not including providing mail order services featuring specialized information relating to drugs and drug therapy; information, advisory and consultancy services relating to all the aforesaid services; including all the aforesaid services provided online from a computer database or the Internet
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
10. Dezember 2022 2022/49 Gaz Löschung
13. November 2015 2015/48 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
06. Januar 2015 2015/28 Gaz TR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
10. September 2014 2014/42 Gaz CN Ablehnung
31. Mai 2014 2014/23 Gaz SG Ablehnung
01. Mai 2014 2014/18 Gaz KR Ablehnung
20. Dezember 2013 2014/4 Gaz TR Ablehnung
26. November 2013 2013/48 Gaz KR Ablehnung
12. September 2013 2013/37 Gaz AU Ablehnung
31. Mai 2012 2013/21 Gaz GB Eintragung

ID: 141160827